Exhibit and on-site guide
APP Conference: November 6, 2025
Fall Conference: November 7-9, 2025 Las Vegas and online
MEETING TIPS
Quick links
For handy access to most of the links mentioned in this guide and to download your certificate of attendance, visit AAN.com/FCQuickLinks
Note: You will need to use the email address associated with your conference registration to access and download your certificate of attendance . Wifi
Network: Caesars_Resorts (no password)
AAN Conferences mobile app and online platform
Download the AAN Conferences mobile app for the most accurate, up-to-the-minute information Enjoy a seamless experience between the mobile app and online platform, which also allow you to revisit past sessions
Conference attendees have access to content through November 24, 2025 . Visit AAN.com/FCOnline and use your 6-digit ID and password to log in to the online platform or view content on the AAN Conferences mobile app . It may take up to 48 hours after session completion for content to become available .
Translate and transcribe sessions
Click the link in the mobile app and web browser to access our translation/ transcription services by Wordly, Inc Enjoy live translation or closed captioning in 60+ languages whether you’re in the room or watching from your hotel room This service is available only for live sessions .
Want more time to review programs?
Add Fall Conference On Demand to your registration to extend your access to session recordings through August 1, 2026, at up to 55% savings This deep discount also includes the APP Conference On Demand! Check the back of your badge to see if you already have Fall Conference On Demand If not, head to registration or go online to corereg.cmrus.com/aanfc by November 24, 2025, to purchase at the discounted rate
MEETING TIPS
Have a question?
Get your question answered by a speaker in real time Join the discussion by logging in to the AAN Conferences mobile app or online platform and navigating to the session you’d like to participate in Select the ‘Q&A’ button at the top of the page and join the discussion!
Program slides
Slides are available through August 1, 2026, at AAN.com/Materials, or through the online platform or AAN Conferences mobile app (through November 24, 2025) . Availability of materials is at the discretion of the specific speaker Not all sessions will have materials
Claiming CME credits
Complete your evaluations to get your CME credits by November 24, 2025 (or August 1, 2026, with Fall Conference On Demand or APP Conference On Demand) by using the AAN Conferences mobile app or by visiting AAN.com/CME. Transcripts will be available upon evaluation submission . AAN members can also access their transcript via NeuroTracker™ at AAN.com/NeuroTracker .
Lunch and coffee breaks
A light breakfast will be provided daily 30 minutes before the start of the first course Lunch and coffee break times and locations are noted in the schedule .
Lactation and prayer rooms
A private room for nursing, pumping, and/or praying is available for use during the conference . Visit Registration for access .
Meeting policies
Complete meeting policies are posted at AAN.com/EventGuidelines
MEETING TIPS
ACCME accreditation
The American Academy of Neurology Institute (AANI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians .
AMA credit designation
The American Academy of Neurology Institute (AANI), a subsidiary of the AAN, designates this live activity for a maximum of (42*) AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity
Non-physicians may claim AMA PRA Category 1 Credit™ as accepted by their licensing or credentialing boards . Participants are responsible for verifying recognition of AMA PRA Category 1 Credit™ with their professional board or licensing body . The AAN will issue documentation indicating participation in an activity certified for AMA PRA Category 1 Credit™ .
ABPN statement
The American Board of Psychiatry and Neurology has reviewed the 2025 AAN Fall Conference and has approved the program as a part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of continuing certification .
Exhibit Hall
Attend the Exhibit Hall Reception on Friday to network with colleagues and make new connections!
Learn about the latest advancements in products and services enhancing the lives of neurology patients and their care providers Stop by the career fair neighborhood, a dedicated area designed for job seekers and employers to meet, network, and discover opportunities in the neurological community . Remember to complete your exhibit hall passport by visiting the participating booths and entering the drawing to win prizes
MEETING-AT-A-GLANCE
Thursday, November 6
(separate registration required)
Advanced Practice Provider Conference
Advanced Practice Provider Conference Morning Programming
Julius 15-19
Lunch/Networking
Julius 13-14
Clinical Foundations in Neurology Track
Julius 15-19
Advanced Clinical Strategies in Neurology Track
Julius 9-11
APP Conference Reception
Julius Foyer
Sponsored by the Association of Movement Disorder Advanced Practice Providers
Friday, November 7
Neurology Update
Julius 15-19
“Best of” the 2025 Annual Meeting
Julius 9-11 Practice Management
Julius 13-14
Leadership University
Julius 6-8
Opening Keynote: Revised McDonald Criteria (2024): Diagnosis and Misdiagnosis of MS in 2024 and Beyond
Julius 15-19
Neuromuscular; Peripheral Nerve
A Clinical Approach to Undifferentiated Gait Disorders
Exhibit Hall Lunch
Julius 12
Neuroophthalmology; NeuroICU/ Emergency Neurology
Dementia; Movement Disorders
Controversies in Neurology
Smart Coding, Smarter Reimbursement: What’s New for Neurology in 2025
How to Keep Your Head While Others Are Losing Theirs
APP Networking Session
Julius 13-14
Clinical Trials in Practice: Building Research and Industry Partnerships from the Ground Up
Clinical Pearls in Autoimmune Neurology: Realworld Cases
AI in Action: Practical Tools for the Neurology Clinic
Exhibit Hall Reception
Julius 12
How to Lead Your Patients in the Information Age
From Crisis to Clarity: Powerful Leadership in Chaos
MEETING-AT-A-GLANCE
Saturday, November 8
Neurology
15-19
Neurohospitalist; Functional Neurologic Disorders
Continuum®: Test Your Knowledge: A Multiple Choice Question Review
Clinical Trials Update
New Myasthenia Gravis Therapies
Stronger Together: Creating a Care Team Culture of Support and Retention
A Guide to Quality Improvement in Neurology
Palliative Care; Epilepsy
CSF Dynamics; Neuro-oncology
Top Ten Neuroophthalmic Diagnoses You Can’t Afford to Miss
Revolutionizing ALS Treatment: The Tofersen Breakthrough
Sunday, November 9
Beyond the Office Visit: Best Practices for Non Face-toface Neurology Care
Advocating for Patients and Practice: Navigating Payer Challenges in Neurology
Skills Workshop: Artificial Intelligence and How to Use It
Neurology Update Julius 15-19 “Best of” the 2025 Annual Meeting Julius 9-11
Multiple Sclerosis; Neuroimmunology/ Neuroinfectious Disease
Cerebrovascular Disease; Headache
Cognitive, Behavioral, and Diseasemodifying Therapeutics in Dementia
The Neuro Exam: Still Relevant!
Neurology solutions tailored to fit your needs
Convenient purchasing from a single source through Cardinal Health™ Metro Medical™ Distribution Services for specialty drugs and medical supplies
Access to competitive pricing and manufacturer rebates on medications through MosaicGPO™ Solutions
Gain visibility into every aspect of your practice with data, contracts and insights you need to strengthen your revenue cycle management and drive business growth
Streamline your practice operations with tools, services and support to help you gain efficiencies, save time and lower costs
SCHEDULE
8:00 a.m.–5:00 p.m.
APP: Advanced Practice
Provider Conference
Location: Julius 15-19
7.25
Learning Objectives: Participants should learn how to apply clinical reasoning and diagnostic skills to evaluate neurological presentations such as altered mental status, stroke, tremors, and demyelinating disorders using history, exam findings, and imaging; perform and interpret neurological exams to localize lesions and identify abnormalities, enhancing diagnostic accuracy and treatment planning; demonstrate procedural and interventional competencies in headache management, neuroimaging interpretation, and coding practices relevant to the APP role; and optimize APP integration through effective billing, documentation, workflow design, and professional development strategies that improve care delivery and team efficiency.
Following the conference, please join us in the Julius Ballroom foyer for a reception sponsored by the Association of Movement Disorder Advanced Practice Providers.
Lecture/Faculty:
8:00 a.m.–8:05 a.m.
Welcome & Introductions
Kristen M. Telfor, MS, NP-C, Mount Pleasant, MI
Ryan Hakimi, DO, FAAN, Greenville, SC
Jaffar Khan, MD, FAAN, Atlanta, GA
8:05 a.m.–8:10 a.m.
Case Study Introduction
Kristen M. Telfor, MS, NP-C, Mount Pleasant, MI
Ryan Hakimi, DO, FAAN, Greenville, SC
Jaffar Khan, MD, FAAN, Atlanta, GA
8:10 a.m.–9:00 a.m.
Altered Mental Status
Mark Milstein, MD, FAAN, Bronx, NY
9:00 a.m.–9:10 a.m. –––––––––––––––––––––Break
9:10 a.m.–9:20 a.m.
Case Study 1
Kristen M. Telfor, MS, NP-C, Mount Pleasant, MI
Ryan Hakimi, DO, FAAN, Greenville, SC
Jaffar Khan, MD, FAAN, Atlanta, GA
9:20 a.m.–10:10 a.m.
Coding, Billing, and Documentation for APPs: What You Need to Know
Emily K. Sweetra, NP, Boston, MA
Raissa Villanueva, MD, FAAN, Rochester, NY
Ryan Hakimi, DO, FAAN, Greenville, SC
10:10 a.m.–10:20 a.m. Break
10:20 a.m.–10:30 a.m.
Case Study 2
Kristen M. Telfor, MS, NP-C, Mount Pleasant, MI
Ryan Hakimi, DO, FAAN, Greenville, SC
Jaffar Khan, MD, FAAN, Atlanta, GA
10:30 a.m.–11:10 a.m.
Neuroimaging
Ryan Hakimi, DO, FAAN, Greenville, SC
11:10 a.m.–11:20 a.m.
Case Study 3
Kristen M. Telfor, MS, NP-C, Mount Pleasant, MI
Ryan Hakimi, DO, FAAN, Greenville, SC
Jaffar Khan, MD, FAAN, Atlanta, GA
11:20 a.m.–12:00 p.m.
Stroke
Kara J. Swafford, MD, Lexington, KY
12:00 p.m.–1:00 p.m.
Lunch/Networking
––––––––––––––––––––––––––––––––––––––– Julius 9-11
1:00 p.m.–1:55 p.m.
Integrating Anti-Amyloid Therapy Into Practice
Britni Johnson, NP, Savannah, GA
1:55 p.m.–2:45 p.m.
Tremors
Orla K. McQuade, NP, Atlanta, GA
Shannon Anderson, PA, Portland, OR
Christopher Caughman, MD, Atlanta, GA
–––––––––––––––––––––––––––––––––––––– Julius 15-19
1:00 p.m.–1:55 p.m.
NeuroExam (Implications of Normal vs Abnormal)
Nassim Zecavati, MD, FAAN, Richmond, VA
1:55 p.m.–2:50 p.m.
Neuroanatomy
Joan Miravite, DNP, RN, FNP-BC, FAAN, FAANP, New York, NY
Kristen M. Telfor, MS, NP-C, Mount Pleasant, MI
2:45 p.m.–2:55 p.m. –––––––––––––––––––––Break
Julius 9-11
2:55 p.m.–3:50 p.m.
Demyelinating Disorders
James N. Brenton, MD, Charlottesville, VA
3:50 p.m.–4:45 p.m. Headache
Jessica Gautreaux, MD, FAAN, New Orleans, LA
–––––––––––––––––––––––––––––––––––––– Julius 15-19
2:55 p.m.–3:50 p.m.
Dizziness
Jaffar Khan, MD, FAAN, Atlanta, GA
3:50 p.m.–4:45 p.m.
Working to Your Potential: Defining and Expanding the Role of the APP
Mona Bahouth, MD, PhD, FAAN, Baltimore, MD
4:45 p.m.–4:55 p.m.
Case Study Finale
Kristen M. Telfor, MS, NP-C, Mount Pleasant, MI
Ryan Hakimi, DO, FAAN, Greenville, SC
Jaffar Khan, MD, FAAN, Atlanta, GA
4:45 p.m.–5:00 p.m.
Wrap-up and Adjourn
Kristen M. Telfor, MS, NP-C, Mount Pleasant, MI
Ryan Hakimi, DO, FAAN, Greenville, SC
Jaffar Khan, MD, FAAN, Atlanta, GA
5:00 p.m.–6:00 p.m.
APP Conference Reception
Friday, November 7
7:30 a.m.–8:30 a.m.
Breakfast
Location: Julius Foyer
8:00 a.m.–9:00 a.m.
C1: Opening Keynote:
Revised McDonald Criteria (2024): Diagnosis and Misdiagnosis of MS in 2024 and Beyond
Location: Julius 15-19
Learning Objectives: Participants should become familiar with the new 2024 McDonald Criteria for the diagnosis of multiple sclerosis with a focus on changes from the 2017 criteria, understand some sources of misdiagnosis of multiple sclerosis, and learn to apply these criteria to specific case vignettes .
Lecture/Faculty:
8:00 a.m.–9:00 a.m.
Revised McDonald Criteria (2024): Diagnosis and Misdiagnosis of MS in 2024 and Beyond
Aaron E. Miller, MD, FAAN, New York, NY
Shhhh... Hear
9:00 a.m.–9:30 a.m.
Break
Location: Julius Foyer
9:30 a.m.–11:00 a.m.
C2: Neurology Update 1: Neuromuscular; Peripheral Nerve 1.5
Location: Julius 15-19
Learning Objectives: Participants should understand the past year’s breakthroughs in antibody-mediated neuropathies, targeted immunotherapies for myasthenia gravis (MG), and gene-replacement strategies for spinal muscular atrophy (SMA) and be able to translate the latest guideline recommendations and pivotal trial data into practical algorithms for outpatient and inpatient care
Lecture/Faculty:
9:30 a.m.–10:15 a.m.
Update in Peripheral Nerve Disorders
Michelle L. Mauermann, MD, FAAN, Rochester, MN 10:15 a.m.–11:00 a.m.
Update in Neuromuscular Disease
Marcus Vinicius R. Pinto, MD, Rochester, MN
9:30 a.m.–11:00 a.m.
C3: A Clinical Approach to Undifferentiated Gait Disorders
Location: Julius 9-11
1.5
Learning Objectives: Participants should be able to recognize the clinical features of common gait disorders seen in adults; formulate a structured approach to the clinical examination that allows better characterization and localization of gait disorders; apply concepts from neurologicrehabilitation and physical therapy to the evaluation and treatment of gait disorders; and demonstrate and apply these new concepts to specific patients in a case-based review .
Lecture/Faculty:
9:30 a.m.–9:45 a.m.
Introduction to Gait Analysis
Meabh O’Hare, MD, Boston, MA
9:45 a.m.–10:15 a.m.
Introduction to Gait Disorders Seen by Neuromuscular Neurology
Meabh O’Hare, MD, Boston, MA 10:15 a.m.–10:45 a.m.
Introduction to Gait Disorders Seen by Movement Neurology
Xenos Mason, MD, Los Angeles, CA 10:15 a.m.–11:00 a.m.
Video Case Based Review of Gait Disorder Presentations
Meabh O’Hare, MD, Boston, MA
Xenos Mason, MD, Los Angeles, CA
9:30 a.m.–11:00 a.m.
C4: Practice Management 1: Smart Coding, Smarter Reimbursement: What’s New for Neurology in 2025
Location: Julius 13-14
Learning Objectives: Get up to speed on new CPT codes, Medicare payment changes, and how to bill for cognitive assessments tied to anti-amyloid therapies Participants should be able to identify key 2024-25 CPT code updates, including changes related to telemedicine and artificial intelligence; explain the impact of the 2025 Medicare Physician Fee Schedule (MPFS) on reimbursement strategies; recognize billing opportunities for cognitive assessments, especially in the context of anti-amyloid therapies; and apply updated coding practices to optimize reimbursement and support clinical decisionmaking .
Lecture/Faculty:
9:30 a.m.–11:00 a.m.
Smart Coding, Smarter Reimbursement
Raissa Villanueva, MD, FAAN, Rochester, NY
Jose M. Rocha, DHA, Medley, FL
Friday, November 7
9:30 a.m.–11:00 a.m.
L1: Leadership University 1: How to Keep Your Head While Others Are Losing Theirs
Location: Julius 6-8
Learning Objectives: The world is constantly changing and the health care landscape is no different . There are continuous shifts, challenges, and complexities to navigate Being able to pivot and navigate the daily pressure requires intentionality, practice, and patience—with yourself and others This interactive workshop offers a space to pause, reflect, and recalibrate to help nurture your resilience and navigate through the chaos Through guided reflection, peer dialogue, and experiential activities, participants will explore practical strategies for staying anchored in personal and professional values, even when things around you feel adrift; using emotionally intelligent approaches to recognize and regulate your responses to stress, uncertainty, and tension; and reframing self-talk and mindset to foster clarity, confidence, and emotional agility. Leadership University sessions are open to all Fall Conference attendees and are designed to be inclusive of advanced practice providers, business administrators, trainees, and neurologists at all career stages . Leadership development is personal development, so please join us!
Lecture/Faculty:
9:30 a.m.–11:00 a.m.
How to Keep Your Head While Others Are Losing Theirs
Mona Bahouth, MD, PhD, FAAN, Baltimore, MD
Robin Stubblefield, MA, ACC, Bloomington, MN
11:00 a.m.–1:00 p.m.
Exhibit Hall Lunch
Location: Exhibit Hall - Julius 12
SCHEDULE
11:00 a.m.–5:30 p.m.
Exhibit Hall & Presentation
Stage
Location: Julius 12
Learning Objectives: Visit the hall to see a live art demo, view exhibitor presentations, and network with our industry partners . Presentation stage schedule:
12:00 p.m.-12:20 p.m.
Presentation by: UCB, Inc. Exploring MOGAD: Disease Recognition and the Phase 3 cosMOG Trial
Speaker: Paul Bromann, PhD
12:00 p.m.–12:45 p.m.
Advanced Practice Provider Networking Session
Location: Julius 13-14
Learning Objectives: Step away from the day-to-day and join fellow APPs for a vibrant, energizing networking session designed to spark new ideas, share insights across specialties, and build meaningful professional connections at the Fall Conference 1:00
Location: Julius 15-19
Learning Objectives: Participants should understand the new guidance for management of ICH, brain death, and status epilepticus and use clinical reasoning to approach difficult cases in neuroophthalmology
Lecture/Faculty: 1:00 p.m.–1:45 p.m.
Update in Neuro-ophthalmology
Sashank Prasad, MD, Philadelphia, PA 1:45 p.m.–2:30 p.m.
Update in Neurocritical Care
Hera A. Kamdar, MD, Columbus, OH
1:00 p.m.–2:30 p.m.
C6: Controversies in Neurology
Location: Julius 9-11
1.5
Learning Objectives: Experts will discuss the most current and controversial issues in neurology using a debate format in which two speakers argue a side of a single topic, followed by a rebuttal .
Lecture/Faculty:
1:00 p.m.–1:45 p.m.
Blood Pressure Targets in ICH: Should We Go Low?
Chitra Venkatasubramanian, MD, MBBS, MSc, FNCS, Palo Alto, CA
Kara R. Melmed, MD, New York, NY
1:45 p.m.–2:30 p.m.
Should CGRP Antagonists Be First Line for Migraine Treatment?
Andrew Charles, MD, Los Angeles, CA
Rebecca C. Burch, MD, Burlington, VT
1:00 p.m.–2:30 p.m.
C7: Practice Management
2: Clinical Trials in Practice: Building Research and Industry Partnerships from the Ground Up 1.5
Location: Julius 13-14
Learning Objectives: Participants should learn how to launch and manage clinical trials in community or private practice settings, navigate key regulations, and build strong industry partnerships—with practical tips on getting started and sustaining success Participants should be able to describe the benefits and challenges of conducting clinical trials in community and private practice settings; identify key regulatory requirements and guidelines for launching and managing clinical trials; apply best practices for initiating and sustaining successful industry partnerships; and explore practical steps to engage with industry collaborators and build a clinical research program from the ground up
Lecture/Faculty:
1:00 p.m.–2:30 p.m.
Clinical Trials in Practice: Building Research and Industry Partnerships from the Ground Up
Mohamad Asaad Nasri, MD, Dallas, TX
Belinda A. Savage-Edwards, MD, FAAN, Huntsville, AL
1:00 p.m.–2:30 p.m.
L2: Leadership University 2: How to Lead Your Patients in the Information Age
Location: Julius 6-8
Learning Objectives: In today’s digital landscape, patients have unprecedented access to health information—and misinformation For neurology professionals, this shift presents both opportunities and challenges: while technology can enhance monitoring and care, it can also confuse, overwhelm, or mislead patients navigating complex neurological diagnoses . This session is designed specifically for neurology professionals seeking to strengthen their role as trusted guides in the digital era, and will provide practical tools to evaluate and incorporate digital technologies in neurologic care . It also aims to teach clinicians how to effectively counsel patients on the quality and credibility of online health information while empowering neurologists to address misinformation and support informed decision-making . Participants will explore key topics including strategies for building digital trust, managing virtual visits, digital communication and etiquette, and addressing digital health inequities—especially in populations with cognitive, motor, or communication challenges . Leadership University sessions are open to all Fall Conference attendees and are designed to be inclusive of advanced practice providers, business administrators, trainees, and neurologists at all career stages . Leadership development is personal development, so please join us!
Lecture/Faculty:
1:00 p.m.–2:30 p.m. How to Lead Your Patients in the Information Age
2:30 p.m.–3:00 p.m.
Break
Location: Julius Foyer
Friday, November 7
Friday, November 7
3:00 p.m.–4:30 p.m.
C8: Neurology Update 3: Dementia; Movement Disorders 1.5
Location: Julius 15-19
Learning Objectives: Participants should gain familiarity with how anti-amyloid monoclonals and next-generation alpha-synuclein antibodies are reshaping treatment paradigms, with emphasis on biomarker-driven patient selection, ARIA monitoring, and evolving coverage policy, and gain familiarity with and be able to apply current best practice in the diagnosis and treatment of Parkinson’s disease, atypical Parkinsonian syndromes, dystonia, essential tremor, ataxia, and chorea Participants will receive an update on major new breakthroughs in these conditions, including new medications, devices, and surgical treatments .
Lecture/Faculty:
3:00 p.m.–3:45 p.m.
Update in Dementia Treatment
Jared R. Brosch, MD, Indianapolis, IN 3:45 p.m.–4:30 p.m.
Update in Movement Disorders
3:00 p.m.–4:30 p.m.
C9: Clinical Pearls in Autoimmune Neurology: Real-world Cases 1.5
Location: Julius 9-11
Learning Objectives: Participants should be able to recognize and become familiar with casebased descriptions of some of neurology’s most treatable autoimmune conditions, spanning the breadth of demyelination, encephalitis, and peripheral neuropathies; recall and interpret investigation features which lead to, and divert from, an accurate autoimmune diagnosis including conditions with antibodies against AQP4, MOG, GAD, LGI1, CASPR2, Iglon5, and NF-155 and formulate, appraise, and synthesize management plans for these patients
Lecture/Faculty:
3:00 p.m.–3:45 p.m.
Clinical Pearls in Autoimmune Neurology: Real-world Cases
Sarosh R. Irani, MD, PhD, FRCP, FEAN, Jacksonville, FL
3:45 p.m.–4:30 p.m.
Confusing Cases from the Brain and Cord
3:00 p.m.–4:30 p.m.
C10: Practice Management
Location: Julius 13-14
Learning Objectives: Discover how neurology teams are using AI to streamline operations, improve ROI, and reduce admin burdens— plus learn practical frameworks, ethical considerations, and advocacy strategies for successful implementation . Participants should be able to describe practical applications of AI in neurology and practice management; evaluate return on investment (ROI) and business case considerations for AI implementation; apply best practices and frameworks for selecting, vetting, and adopting AI technologies; and identify key ethical and legal considerations when integrating AI into clinical operations .
Lecture/Faculty:
3:00 p.m.–4:30 p.m.
AI in Action: Practical Tools for the Neurology Clinic
Lee Williams, Amherst, NY
Shawn N. Murphy, MD, Medway, MA
3:00 p.m.–4:30 p.m.
L3: Leadership University 3: From Crisis to Clarity: Powerful Leadership in Chaos
Location: Julius 6-8
Learning Objectives: What do a past AAN President, a CEO, and a Deputy Commander at the largest military health care organization within the Department of Defense have in common? Come find out! Through powerful storytelling, three leaders will share the challenges they faced and the guiding principles that supported them while leading their organizations through the COVID-19 pandemic and other challenging times Participants will gain actionable strategies for effective leadership in times of crisis, regardless of the context Leadership University sessions are open to all Fall Conference attendees and are designed to be inclusive of advanced practice providers, business administrators, trainees, and neurologists at all career stages . Leadership development is personal development, so please join us!
Lecture/Faculty:
3:00 p.m.–4:30 p.m.
From Crisis to Clarity: Powerful Leadership in Chaos
Jeffrey C. McClean II, MD, FAAN, San Antonio, TX
Carolyn M. Chamberlain, CMPE, Asheville, NC
James C. Stevens, MD, FAAN, Fort Wayne, IN
4:30 p.m.–5:30 p.m.
Exhibit Hall Reception
Location: Exhibit Hall - Julius 12
Friday, November 7
7:30 a.m.–8:30 a.m.
Breakfast
Location: Julius Foyer
8:00 a.m.–9:30 a.m.
C11: Neurology Update 4: Neurohospitalist; Functional Neurologic Disorders
Location: Julius 15-19
Learning Objectives: Participants should be able to sharpen their bedside reasoning for complex inpatients, then pivot to positive-sign diagnosis and interdisciplinary management of functional neurologic disorder (FND) grounded in the latest practical management data
Lecture/Faculty:
8:00 a.m.–8:45 a.m.
Clinical Reasoning in Inpatient Neurology
Aaron L. Berkowitz, MD, PhD, FAAN, San Bruno, CA
8:45 a.m.–9:30 a.m.
Update in Functional Neurological Disorders
Sara A. Finkelstein, MD, Boston, MA
8:00 a.m.–9:30 a.m.
C12: Clinical Trials Update
Location: Julius 9-11
Learning Objectives: This session covers landmark clinical trials that affect patient care in every subspecialty of neurology Investigators will present the latest clinical trials results that are impacting the landscape of neurological care
Lecture/Faculty:
8:00 a.m.–8:30 a.m.
New Perspectives on Restless Legs Syndrome Management
LynnMarie Trotti, MD, Atlanta, GA
8:30 a.m.–9:00 a.m.
Updates in the Management of Advanced Parkinson’s Disease
Okeanis Vaou, MD, FAAN, San Antonio, TX
9:00 a.m.–9:30 a.m.
Thrombectomy for Large Core Ischemic Strokes
Ronda Lun, MD, Calgary, AB, Canada
8:00 a.m.–9:30 a.m.
C13: Practice Management 4: Stronger Together: Creating a Care Team Culture of Support and Retention
Location: Julius 13-14
1.5
Learning Objectives: Discover effective strategies for onboarding, training, and retaining key staff, with a focus on supporting APPs and MAs while fostering a strong, sustainable team environment . Participants should be able to apply best practices for onboarding and training advanced practice providers (APPs), medical assistants (MAs), and other key staff; identify strategies to support and retain APPs in both clinical and administrative roles; implement effective engagement and retention approaches for MAs and practice management staff; and foster a supportive team culture that promotes long-term staff satisfaction and performance
Lecture/Faculty:
8:00 a.m.–9:30 a.m.
Stronger Together: Creating a Care Team Culture of Support and Retention
Louis A. Tramontozzi III, MD, Beverly, MA
Shannon Anderson, PA, Portland, OR
8:00 a.m.–10:30 a.m.
Florbetapir F 18 Live Reader Training by Eli Lilly and Company
Location: Julius 21-22
Learning Objectives: Florbetapir F 18 is a radioactive diagnostic agent for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline Florbetapir F 18 reader training aims to equip attendees with essential skills for accurately interpreting florbetapir amyloid PET scans
To register for this training, visit https://meetings.lilly.com/ aaMa9q?rt=uq6SEWjzbEy0Iv6UOhUJSA .
9:30 a.m.–10:00 a.m.
Exhibit Hall Break
Location: Exhibit Hall - Julius 12
9:30 a.m.–1:00 p.m.
Exhibit Hall & Presentation Stage
Location: Julius 12
Learning Objectives: Visit the hall to see a live art demo, play NeuroTrivia, and network with our industry partners .
10:00 a.m.–11:30 a.m.
C14: Continuum® Test Your Knowledge: A Multiplechoice Question Review
Location: Julius 15-19
Learning Objectives: Participants should become familiar with the diagnosis and treatment of epilepsy and neuroophthalmologic disorders .The American Board of Psychiatry and Neurology has reviewed the Continuum® Test Your Knowledge: A Multiple-choice Question Review course and has approved this activity as part of a comprehensive Self-assessment (SA) CME activity, which is compliance with the ABMS continuing certification standards
Lecture/Faculty:
10:00 a.m.–10:45 a.m.
Epilepsy/Clinical Neurophysiology
Jennifer L. Hopp, MD, FAAN, Baltimore, MD 10:45 a.m.–11:30 a.m.
Neuro-ophthalmology
Nancy J. Newman, MD, FAAN, Atlanta, GA
10:00 a.m.–11:30 a.m.
C15: New
Myasthenia Gravis Therapies
Location: Julius 9-11
1.5
Learning Objectives: Participants should be able to understand the history and evolution of myasthenia gravis treatments from acetylcholinesterase inhibitors and oral immunosuppressants to the development of novel targeted therapies; understand the mechanisms of action of novel myasthenia gravis treatment, including complement inhibitors and neonatal Fc receptor (FcRn) blockers; and learn how to integrate antibody subtype, disease severity and comorbidities to develop indivdualized treatment strategies .
Lecture/Faculty:
10:00 a.m.–10:40 a.m.
Myasthenia Gravis: The Evolving Treatment Landscape
Michael Slama, MD, PhD, Boston, MA 10:40 a.m.–10:45 a.m.
Questions And Answers
Michael Slama, MD, PhD, Boston, MA 10:45 a.m.–11:25 a.m.
Myasthenia Gravis Management in the Era of Targeted Immunotherapies: A Case-based Approach
Christyn M. Edmundson, MD, Seattle, WA 11:25 a.m.–11:30 a.m.
Questions and Answers
Christyn M. Edmundson, MD, Seattle, WA
Saturday, November 8
10:00 a.m.–11:30 a.m.
C16: Practice Management
5: A Guide to Quality Improvement in Neurology
Location: Julius 13-14
Learning Objectives: Turn your improvement idea into impact—learn how to use proven tools like PDSA cycles, measure what matters, and pitch your project with confidence, all while aligning with key quality initiatives and driving lasting change . Participants should be able to use proven quality improvement tools—like PDSA cycles and cause-andeffect diagrams—to design and refine impactful projects; define success in process improvement using meaningful metrics and key performance indicators (KPIs); craft a compelling elevator pitch to communicate the value of their improvement initiative; and align their efforts with current quality reporting requirements and implement strategies for long-term sustainability.
Lecture/Faculty:
10:00 a.m.–11:30 a.m.
A Guide to Quality Improvement in Neurology
Justin P. Martello, MD, FAAN, Newark, DE
David A. Evans, MBA, DAAN, Dallas, TX
11:30 a.m.–1:00 p.m.
Exhibit Hall Lunch
Location: Exhibit Hall - Julius 12
11:45 a.m.–12:45 p.m.
NeuroTrivia
Location: Julius 12
Learning Objectives: NeuroTrivia is a fun, interactive ‘quiz show’ where contestants will test their diagnostic acumen over a series of challenging neurological case presentations . In addition, the full audience will also be able to play along to see who lands at the top of the leader board . Interesting, practical teaching points will accompany each case to solidify important clinical concepts and takehome messages
Lecture/Faculty: 11:45 a.m.–12:45 p.m.
NeuroTrivia
Sashank Prasad, MD, Philadelphia, PA
Raymond Price, MD, FAAN, Philadelphia, PA
12:00 p.m.–12:45 p.m.
Business Administrators
Networking Session
Location: Julius 13-14
Learning Objectives: Connect with fellow business administrators across practice settings in this dynamic networking session designed to foster collaboration, share best practices, and build lasting professional relationships that support leadership and operational excellence in neurology
12:00 p.m.–1:00 p.m.
Industry Therapeutic
Update from Lilly: Clinical Decision Making with Kisunla (donanemab-azbt).
Location: Julius 4
Learning Objectives: Join us for an educational session where we will discuss how to identify appropriate patients, efficacy and established safety profile from our latest clinical trials . Please see the Important Safety Information, including Boxed Warning regarding ARIA, the Full Prescribing Information, and Medication Guide provided at the Product Theater and at https://kisunla . lilly com/hcp This program is sponsored by, and the speaker is presenting on behalf of, Lilly USA, LLC . It is being presented consistent with FDA guidelines and is not approved for continuing education credit . This program is not accredited for continuing education by any organization. Additionally, Industry Therapeutic Updates program content and the views expressed herein are those of the presenting corporate entity and not of the AAN. These programs are not an official part of the 2025 Fall Conference education or scientific programs, nor are they endorsed by the AAN. The AAN cannot affirm claims pertaining to FDA off-label medication, research use of pre-FDA drugs, or other research information that might be discussed. Industry Therapeutic Updates are industry events.
12:00 p.m.–1:00 p.m.
Industry Therapeutic Update from Harmony Biosciences: Explore WAKIX® (pitolisant) as a Treatment Option for
Your Patients
Location: Julius 1-2
Learning Objectives: Hear Gerard Meskill, MD, discuss how WAKIX is thought to work, review clinical study results, and share more information on prescribing . This program is not accredited for continuing education by any organization. Additionally, Industry Therapeutic Updates program content and the views expressed herein are those of the presenting corporate entity and not of the AAN. These programs are not an official part of the 2025 Fall Conference education or scientific programs, nor are they endorsed by the AAN. The AAN cannot affirm claims pertaining to FDA off-label medication, research use of pre-FDA drugs, or other research information that might be discussed. Industry Therapeutic Updates are industry events.
1:00 p.m.–2:30 p.m.
C17: Neurology Update 5: Palliative Care;
Epilepsy 1.5
Location: Julius 15-19
Learning Objectives: Participants should become familiar with common clinical scenarios and management tools relevant for palliative care in the setting of neurological disease; learn the latest approaches to diagnosis and treatment of seizure disorders; learn the updated names for the various types of seizures; understand the new classification of the different epilepsy syndromes; know when to treat a first seizure; learn when it is reasonable to stop antiseizure medications; plan how to treat acute repetitive seizures (clusters); know the three stages of status epilepticus and the guidance on how to treat them; and understand the newest information on pregnancy management and driving advice .
Lecture/Faculty:
1:00 p.m.–1:45 p.m.
Update in Neuropalliative Care
Maisha T. Robinson, MD, MS, FAAHPM, FAAN, Jacksonville, FL
1:45 p.m.–2:30 p.m.
Update in Epilepsy
David G. Vossler, MD, FAAN, Bellevue, WA
1:00 p.m.–2:30 p.m.
C18: Top Ten Neuroophthalmic Diagnoses You Can’t Afford to Miss
Location: Julius 9-11
Learning Objectives: Ten neuroophthalmology cases will be presented, as they are in the clinic, for participants to solve by choosing the next piece of history, exam finding, or diagnostic test to arrive at the correct diagnosis to avoid morbidity, blindness, etc, or mortality if the diagnosis is not made within the alloted timeframe .
Lecture/Faculty: 1:00 p.m.–2:30 p.m.
Top Ten Cases
Wayne T. Cornblath, MD, FAAN, Ann Arbor, MI
Eric R. Eggenberger, DO, FAAN, Jacksonville, FL
1:00 p.m.–2:30 p.m.
C19: Practice Management
6: Beyond the Office Visit: Best Practices for Non Face-to-face Neurology
Care
Location: Julius 13-14
Learning Objectives: Get practical tips for managing in-basket workflows, telehealth, and e-consults across settings, while exploring strategies for chronic care management and opportunities to engage with the GUIDE model—even if you didn’t enroll . Participants should be able to apply best practices for efficient in-basket and inbox management across clinical settings and subspecialties; implement and optimize telehealth and e-consult workflows using technology-driven strategies; design and sustain effective Chronic Care Management (CCM) programs using digital tools; and explore opportunities to engage with the GUIDE model and other tech-enabled care initiatives, even without prior enrollment
Lecture/Faculty: 1:00 p.m.–2:30 p.m.
Beyond the Office Visit: Best Practices for Non Face-to-face Neurology Care
Jessica Gautreaux, MD, FAAN, New Orleans, LA Allison Tobin, Beverly, MA
Saturday, November 8
1:00 p.m.–4:30 p.m.
C20: Skills Workshop: Artificial Intelligence and How to Use It
Location: Julius 6-8
Learning Objectives: Participants should be able to define core AI concepts and identify key risks; use structured prompts for clinical, educational, and administrative tasks; appraise clinical research and differentiate appropriate AI use cases; critique AI outputs for bias, safety, and clinical accuracy; and design novel patient resources and a personal action plan . Participants are asked to bring a laptop with ChatGPT and Claude preinstalled .
Lecture/Faculty:
1:00 p.m.–1:15 p.m.
Intro to AI
Erick Tarula, MD, Madison, WI
1:15 p.m.–1:40 p.m.
Mastering the Prompt Tanya Horsley, PhD, MBA, Ottawa, ON, Canada
1:40 p.m.–2:10 p.m.
AI as Your Research Assistant
Braydon Dymm, MD, Charleston, WV
2:10 p.m.–2:30 p.m.
Creating Educational Content in Minutes Galina Gheihman, MD, Boston, MA
2:30 p.m.–2:50 p.m.
AI for Patient Communication
Rameez A. Merchant, MBBS, Columbia, MO
2:30 p.m.–3:00 p.m.
Break
Location: Julius Foyer
3:00 p.m.–4:30 p.m.
C21: Neurology Update 6: CSF Dynamics; Neurooncology
Location: Julius 15-19
Learning Objectives: Participants should learn about updates on the latest approaches to diagnosis and treatment of CSF dynamics disorders (e g , normal pressure hydrocephalus, spontaneous intracranial hypotension) and neuro-oncologic disorders .
Lecture/Faculty:
3:00 p.m.–3:45 p.m.
Update in CSF Dynamics
Jeremy K. Cutsforth-Gregory, MD, FAAN, Rochester, MN
3:45 p.m.–4:30 p.m.
Update in Neuro-oncology
Amy A. Pruitt, MD, FAAN, Philadelphia, PA
3:00 p.m.–4:30 p.m.
C22: Revolutionizing ALS
Location: Julius 9-11
Learning Objectives: Participants should be able to describe the utility of genetic testing in amyotrophic lateral sclerosis (ALS); discuss the use of antisense oligonucleotide therapy for SOD1 ALS; and implement a neuromuscular rehabilitation program for patients with ALS who have stabilized .
Lecture/Faculty:
3:00 p.m.–3:45 p.m.
Tofersen Therapy for ALS
Timothy M. Miller, MD, PhD, Saint Louis, MO
3:45 p.m.–4:30 p.m.
Neuromuscular Rehabilitation in Successfully
Treated ALS Patients
Sean E. Smith, MD, MPHS, Saint Louis, MO
SCHEDULE
3:00 p.m.–4:30 p.m.
C23: Practice Management
7: Advocating for Patients and Practice: Navigating Payer Challenges in Neurology
Location: Julius 13-14
Learning Objectives: Learn how to manage payer challenges like prior authorizations, reduce administrative burdens with smart tools and strategies, address reimbursement complexities, and advocate for both your patients and your practice . Participants should be able to identify key challenges and opportunities in navigating payer relations, including prior authorizations and reimbursement complexities; apply strategies and technology tools to reduce administrative burden in clinical practice; develop effective appeal approaches to address denials, with an emphasis on underutilized high-approval opportunities; and strengthen advocacy
skills to support both patient access and provider well-being in the face of increasing administrative demands
Lecture/Faculty:
3:00 p.m.–4:30 p.m.
Advocating for Patients and Practice: Navigating Payer Challenges in Neurology
Kavita Nair, PhD, FAAN, Aurora, CO
Carolyn M. Chamberlain, CMPE, Asheville, NC
Started taking WAKIX in 2020
7:00 a.m.–8:00 a.m.
Breakfast
Location: Julius Foyer
7:30 a.m.–9:00 a.m.
C24: Neurology Update
7: Multiple Sclerosis; Neuroimmunology/ Neuroinfectious Disease
Location: Julius 15-19
Learning Objectives: Participants should understand the latest approaches to diagnosis and treatment of multiple sclerosis and common neuroimmunologic and neuroinfectious diseases; become familiar with the new MS diagnostic criteria including the role of the optic nerve and imaging findings; understand treatment updates in multiple sclerosis, including recent clinical trial results; and understand more about emerging therapies in MS .
Lecture/Faculty:
7:30 a.m.–8:15 a.m.
Update in Multiple Sclerosis
Kristin M. Galetta, MD, Palo Alto, CA
8:15 a.m.–9:00 a.m.
Update in Infectious Disease
Shamik Bhattacharyya, MD, FAAN, Boston, MA
7:30 a.m.–9:00 a.m.
C25: Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia
Location: Julius 9-11
Learning Objectives: Participants should become familiar with the indication for and clinical utility of pharmacological and nonpharmacological therapeutics for dementiarelated cognitive and behavioral symptoms; learn about the proper utilization of diseasemodifying treatments for dementia and their role in clinical practice; and apply principles of behavioral tools and indications for pharmacological management and disease-modifying treatment for dementia by selecting appropriate therapies
Lecture/Faculty:
7:30 a.m.–7:35 a.m.
Introduction
Lealani M. Acosta, MD, MPH, FAAN, Nashville, TN
7:35 a.m.–8:00 a.m.
Non-Pharmacological Management of Dementia
Helen Kales, MD, Sacramento, CA
8:00 a.m.–8:25 a.m.
Pharmacological Management of Dementia
Lealani M. Acosta, MD, MPH, FAAN, Nashville, TN
8:30 a.m.–8:55 a.m.
Disease-Modifying Therapeutics in Dementia
Meredith Wicklund, MD, FAAN, Scottsdale, AZ
8:55 a.m.–9:00 a.m.
Q&A for Disease-Modifying Therapeutics in Dementia
Meredith Wicklund, MD, FAAN, Scottsdale, AZ
9:00 a.m.–9:30 a.m.
Break
Location: Julius Foyer 9:30 a.m.–11:00 a.m. C26: Neurology Update 8: Cerebrovascular Disease; Headache 1.5
Location: Julius 15-19
Learning Objectives: Participants should understand the latest approaches to diagnosis and treatment of cerebrovascular disorders and headache disorders
Lecture/Faculty:
9:30 a.m.–10:15 a.m.
Update in Cerebrovascular Disease
Victor J. Del Brutto, MD, Key Biscayne, FL
10:15 a.m.–11:00 a.m.
Update in Headache
Hannah Park, MD, Haddonfield, NJ
9:30 a.m.–11:00 a.m.
C27: The Neuro Exam: Still Relevant! 1.5
Location: Julius 9-11
Learning Objectives: Two expert clinical neurologists will present insights into the performance and interpretation of the neurological examination
Lecture/Faculty:
9:30 a.m.–11:00 a.m.
The Neuro Exam: Still Relevant!
Amy A. Pruitt, MD, FAAN, Philadelphia, PA
Nancy J. Newman, MD, FAAN, Atlanta, GA
Join Us
Endeavor Health
Neurosciences Institute is hiring!
Serving the Chicagoland area— including the north, northwest, and western suburbs
At Endeavor Health Neurosciences Institute, we are leading experts in the advancement of brain and nervous system care. As one of the largest, most comprehensive neuroscience programs in the region, our Institute brings together nationally recognized experts across every neurological subspecialty to deliver world-class, patient-centered care.
Current Opportunities include:
General Neurologist
Behavioral Neurologist
Headache Neurologist
Epilepsy Neurologist – Section Head
Neurointerventionalist
Neuromuscular specialist
Neuro-oncologist
Neurology/Sleep specialist
Neuro Vascular
MS Neurologist
Contact: Shawn A. Watzka
Senior Physician Recruiter swatzka@northshore.org
EXHIBIT HALL MAP
EXHIBITORS
AbbVie
Booth 709
abbvie.com
AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow We strive to have a remarkable impact on people’s lives across several key therapeutic areas For more information about AbbVie, please visit us at www abbvie com .
Advocate Health
Booth 412
advocatehealth.org
Advocate Health is the third-largest nonprofit integrated health system in the U S , created by the combination of Advocate Aurora Health and Atrium Health in December 2022 The organization operates across six states (Illinois, Wisconsin, North Carolina, Georgia, Alabama, and South Carolina) with Wake Forest University School of Medicine as its academic core . Advocate Health serves nearly 6 million patients at over 1,000 care locations and 69 hospitals, focusing on clinical innovation, improving patient outcomes, and community well-being
Alexion, AstraZeneca
Rare
Disease
Booth 612
alexion.com
Alexion Pharmaceuticals is a US-based, rare disease-focused pharmaceutical company, now known as Alexion, AstraZeneca Rare Disease . Headquartered in Boston, Massachusetts, the company specializes in developing and delivering life-changing therapies for rare and devastating conditions, leveraging its expertise in the complement system and patient-centric R&D to address unmet medical needs
American Parkinson Disease Association
Booth 710
apdaparkinson.org
The American Parkinson Disease Association (APDA) is a nationwide grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to help the approximately one million people with PD in the United States live life to the fullest in the face of this chronic neurological disorder. Founded in 1961, APDA has raised and invested more than $313 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and ultimately put an end to this disease . To join in the fight against PD and to learn more about the support APDA provides nationally through a network of Chapters and Information & Referral (I&R) Centers, as well as a national Research Program and APDA Centers for Advanced Research, please explore our website, make a donation, or contact us at any time
Amgen
Booth 525
amgen.com
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases . Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index® In 2025, Amgen was named to Fortune’s list of the World’s Most Admired Companies
argenx
Booth 609
argenx.com
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines . argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises For more information, visit www argenx com
argenx
Booth 715
argenx.com
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases . Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines . argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker and is evaluating its broad potential in multiple serious autoimmune diseases while advancing several earlier stage experimental medicines within its therapeutic franchises For more information, visit www argenx com
AstraZeneca
Booth 313
astrazeneca.com
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, Respiratory & Immunology Based in Cambridge, UK, AstraZeneca operates in over 100 countries . Its innovative medicines are used by millions of patients worldwide . For more information, please visit www . astrazeneca-us .com or Twitter @AstraZeneca US
Aura
Booth 315
aurahealthyliving.com
Aura Healthy Living provides wellnessfocused solutions designed to support health professionals and their patients . With an integrative approach and a focus on quality, Aura offers tools that promote balance, cognitive well-being, and overall resilience .
Autonomy Health
Booth 608
autonomyhealth.io
Autonomy Health is purpose-built for neurology . We use AI to eliminate the manual work behind the most critical practice management workflows— eligibility, referrals, prior auth, and billing . This enables practices to add ancillary services like infusions with less overhead The result: more income, greater independence, and better patient care
Axsome Therapeutics
Booth 622
axsome.com
Axsome is developing therapies for CNS conditions with limited treatment options . By creating treatments with novel mechanisms of action, we are transforming the approach to treating CNS conditions At Axsome, we are committed to developing therapeutic approaches that meaningfully improve the lives of patients and provide additional options for physicians .
BJC Health System
Booth 510
bjccareers.org/providercareers/jobs
BJC Medical Group, part of the BJC HealthCare network, offers a dynamic platform for personal, professional, and financial growth with a robust compensation and rewards package Backed by 650+ physicians and specialists, we deliver exceptional care to thousands across St Louis, mid-Missouri, and Southern Illinois We have dedicated experts handling revenue cycle, coding, compliance, and marketing so you can focus on what matters most—providing outstanding, patient-centered care that makes a lasting impact .
Cala Health
Booth 514
calahealth.com
The Cala kIQ™ System with TAPS (Transcutaneous Afferent Patterned Stimulation) therapy is the only FDAcleared, wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor (ET) or Parkinson’s disease (PD) . The TAPS device is physicianprescribed and clinically proven to safely and effectively manage action hand tremors
Cardinal Health
Booth 617
cardinalhealth.com/neurology
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities Cardinal Health’s Neurology offering includes tailored solutions to strengthen financial performance and streamline operations, purchasing power through MosaicGPO™
Solutions and national distribution of pharmaceuticals and medical supplies through Metro Medical™ Distribution Services . Catalyst Pharmaceuticals
Booth 708
catalystpharma.com
Catalyst is committed to developing and commercializing novel medicines for patients living with rare and difficult to treat neurological diseases
Craniometrix
Booth 714
craniometrix.com
Leveraging Medicare’s new GUIDE program, Craniometrix provides non-clinical care support to dementia patients -- and gets their doctors paid for it! Patients and families receive 24/7 support, powered by the MIND at Home Program created at Johns Hopkins, with published outcomes including a 27% reduction in hospitalization You retain clinical ownership and can expect to earn over $200,000 in profit per 250 eligible patients Join over 300 other private practice neurologists across the country -- stop by and say hi!
Creyos
Health
Booth 712
creyos.com
Creyos is a digital cognitive and behavioral health assessment platform trusted by neurologists worldwide Built on 30+ years of neuroscience research and validated across 400+ peer-reviewed studies, Creyos assessments deliver objective data that strengthens diagnostic accuracy, accelerates clinical decisions, and simplifies longitudinal tracking . With reports delivering neuropsychological precision in minutes, Creyos reduces unnecessary referrals and empowers faster, more confident cognitive care for better patient outcomes Learn more about Creyos at creyos com
Eisai, Inc.
Booth 311
us.eisai.com
Eisai Inc . is a human health care (hhc) company dedicated to pursuing innovative research and simplifying the treatment journey to help improve the lives of people affected by cancer, Alzheimer’s disease and other neurodegenerative conditions Learn more: https://us eisai com and connect with us on X and LinkedIn
Eli Lilly and Company
Booth 423
Lilly.com
Lilly unites caring with discovery to create medicines that make life better for people around the world We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe . Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases . With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people . That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable
Eli Lilly and Company
Booth 509
Lilly.com
Lilly unites caring with discovery to create medicines that make life better for people around the world . We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe . Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases . With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable .
Endeavor Health
Booth 414
endeavorhealth.org/services/ behavioral-health
At Endeavor Health’s Neurological Institute, we are at the forefront of advancing brain and nervous system care . As one of the largest, most comprehensive neuroscience programs in the region, our Institute brings together nationally recognized experts across every neurological subspecialty to deliver world-class, patient-centered care Serving the Chicagoland area—including the NorthShore, Northwest, and Western suburbs—we provide access to leading-edge treatments close to home . From pioneering therapies in epilepsy, stroke, and neuro-oncology, to groundbreaking research and clinical trials, we are committed to improving outcomes and transforming lives . Our collaborative, multidisciplinary approach ensures patients benefit from the latest innovations in diagnostics, therapies, and surgical techniques—all delivered with compassion, expertise, and an unwavering focus on hope and healing .
Essentia Health
Booth 413
EssentiaHealth.org
Essentia Health is a physician-led, non-profit, integrated health system serving patients in Minnesota, North Dakota, and Wisconsin Headquartered in Duluth, Minnesota, Essentia Health combines the strengths and talents of more than 15,000 employees, including more than 2,350 physicians and advanced practitioners, who serve our patients and communities through the mission of being called to make a healthy difference in people’s lives . Essentia Health, which includes many Catholic facilities, is guided
by the values of Quality, Hospitality, Respect, Joy, Justice, Stewardship, and Teamwork The organization lives out its mission by having a patientcentered focus at 14 hospitals, 80 clinics, 30 retail pharmacies, six longterm care facilities, three assisted living facilities, two independent living facilities, seven ambulance services, and one research institute .
Genentech
Booth 613
gene.com
Founded nearly 50 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions . The company, a member of the Roche Group, has headquarters in South San Francisco, California
Harmony Biosciences
Booth 623
WAKIXhcp.com
Harmony Biosciences specializes in developing and delivering treatments for rare neurological diseases . We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases Our team of experts from a wide variety of disciplines and experiences are driven by our shared conviction that innovative science translates into therapeutic possibilities for patients, who are at the heart of everything we do . We recognize the impact that symptoms of rare neurological diseases can have on daily life, and we consider that impact when developing and bringing new therapies to market .
HSHS Hospital Sisters Health System
Booth 409
hshs.org/medical-group/careers/ provider-employment-opportunities
Throughout communities in Illinois and Wisconsin, 13 hospitals, numerous community-based health centers and clinics, our 13,000+ colleagues have built a culture based on our solid core values of respect, care, competence, and joy . These are the ideals we believe in, work by, and live each day . Built upon more than 145 years of service to the communities we serve, we now look to the future and our place in it as a health care system that strives to continually improve processes, procedures, and outcomes with the latest and most advanced technologies and treatments Regardless of how far our passion for excellence carries us, our focus will always remain on the most important person in our entire organization: The patient .
Impel
Pharmaceuticals
Booth 716
impelpharma.com
Impel Pharmaceuticals is the first company to harness the benefits of delivery to the upper nasal space to improve the therapeutic potential of medicines for people suffering from diseases with high unmet medical needs Unlike traditional nasal delivery systems, such as pumps, that predominantly deliver medicine to the lower nasal space and suffer from high variability and low overall absorption, our therapies are designed to achieve rapid absorption with consistent and predictable doses . The upper nasal space is believed to be a gateway for improved absorption and hence, the potential for enhanced clinical
outcomes and on-demand access for molecules previously limited to injection and hospital-based use .
IPSEN Biopharmaceuticals Inc.
Booth 317
ipsenus.com
Ipsen is a global biopharmaceutical company focused on innovation and specialty care At Ipsen, we develop and commercialize medicines in three key therapeutic areas – Oncology, Neuroscience and Rare Disease . We work to provide hope for patients whose lives are challenged by difficult-to-treat diseases, including neurological disorders such as certain types of spasticity and cervical dystonia Our people are driven by a passion to help patients and bring our mission to life every day We are always ready to listen to—and learn from—patients . Every day, our more than 5,700 employees worldwide, including over 600 in North America, work diligently to improve the lives of patients around the world . For more information please visit www .ipsenus . com .
IPSEN Biopharmaceuticals Inc.
Booth 717
ipsenus.com
Ipsen is a global biopharmaceutical company focused on innovation and specialty care . At Ipsen, we develop and commercialize medicines in three key therapeutic areas – Oncology, Neuroscience and Rare Disease We work to provide hope for patients whose lives are challenged by difficult-to-treat diseases, including neurological disorders such as certain types of spasticity and cervical dystonia . Our people are driven by a passion to help patients and bring our mission to life every day . We are always ready to listen to—and learn from—patients . Every day, our more than 5,700 employees worldwide, including over 600 in North America, work diligently to improve the lives of patients around the world For more information please visit www ipsenus com
JM Brain Tumor Foundation
Booth 325
Jmbraintumorfoundation.com
Created by a brain tumor survivor, our booth offers empowering books and guided journals for brain tumor warriors and survivors, anxiety and grounding bundles, and inspiring custom apparel including t-shirts and hoodies Every item is designed to uplift, support, and celebrate the strength of those impacted by brain tumors .
Johnson & Johnson
Booth 723 jnj.com
At Johnson & Johnson, we believe health is everything . As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care .
Kaba Fusion
Booth 425 kabafusion.com
KabaFusion is a national, patientfocused home infusion company specializing in IVIG, SCIG, Chronic and Acute IV therapies . As an industry leader, with over 30 years’ experience in home-infusion, we provide comprehensive support to our patients and providers before, during and after treatment We truly believe in putting the “care” back in healthcare
Kyverna Therapeutics
Booth 719
kyvernatx.com
Kyverna Therapeutics, Inc . is a clinical-stage biopharmaceutical company focused on liberating patients through the curative potential of cell therapy Kyverna’s lead CAR T-cell therapy candidate, KYV-101, is advancing through late-stage clinical development with registrational trials for stiff person syndrome and myasthenia gravis . Kyverna is also harnessing other KYSA trials and investigator-initiated trials to inform the next priority indications . Additionally, its pipeline includes next-generation CAR T-cell therapies in both autologous and allogeneic formats .
Loma Linda University Faculty Medical Group
Booth 411 fmg.lluh.org
Loma Linda University Faculty Medical Group (LLUFMG) is a diverse community of passionate and supportive clinician educators . We are grounded in the daily pursuit of clinical and academic excellence, holistic health promotion, faith in a higher calling, and the healing value of human connection .
Lundbeck
Booth 614
lundbeck.com/us
Lundbeck is a global biopharmaceutical company focusing exclusively on brain health . With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases . Brain disorders affect a large part of the world’s population, and the effects are felt throughout society With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatment . Visit www . lundbeckus .com .
consults & complex notes, supports pre-charting and combining MA and physician workflows, generates aftervisit summaries, referral letters, and DDx reports, and generates ICD-10 CM and E/M codes along with MDM rationale, and integrates 2-way with 12 leading EHRs
Mayo Clinic Laboratories
Booth 724
mayocliniclabs.com
Mayo Clinic Laboratories strives to ensure patients around the world have access to the most advanced diagnostic testing Working with hospitals and healthcare providers worldwide, we deliver the latest in diagnostic testing to provide answers and improve outcomes for their patients . With the world’s most sophisticated test catalog, our testing incorporates scientific discoveries, cutting-edge technologies, and unparalleled expertise to solve the most rare and complicated cases
Medpro
Booth 511 medproinfo.org
A company that specializes in the latest technology in the medical field .
Marvix AI
Booth 422
marvixapp.ai
Marvix AI is an ambient AI assistant for Neurology It listens securely to patient visits and combines them with the patient’s historical record from the EHR to create structured clinical notes in your writing style for the problems that you see most - headache, dementia, epilepsy . Marvix is built for long
Mirum Pharmaceuticals Booth 513
mirumpharma.com
Mirum proudly serves children, adults, and families with rare disease, working closely with these communities to intimately understand the challenges they face day to day It’s with this deep understanding, empathy, and urgency that we seek to develop remarkable therapies for rare diseases that have limited or no approved treatment options . Because ultimately, our goal is to transform the lives of these individuals so that they have the opportunity to live life to the fullest .
Myasthenia Gravis Holistic Society
Booth 516
mgholisticsociety.org
Octapharma Booth 515
octapharmausa.com
Family-owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland Our products are available in 118 countries and reach hundreds of thousands of patients every year . We focus on three therapeutic areas: hematology, immunotherapy, and critical care . Octapharma is one of the largest human protein product manufacturers . We develop and produce medicines based on human proteins from human cell lines and human plasma, sourced from our own plasma donation centers and other external sources
Our passion drives us to provide new health solutions advancing human life
This vision serves as our navigational reference point .
OPED Medical
Booth 522
us.o-dhs.com
Gait analysis is vital tool for diagnosing, monitoring and the understanding of neurological diseases Utilizing various tools for gait analysis is essential for neurological diagnosis but also for treatment and prognosis Within 5 minutes, Orthelligent Vision is able to provide an accurate and comprehensive full gait analysis . It quantifies key biomechanical parameters and visualizes patient’s performance, achieving > 98 correlation with Marker-based Analysis which is time consuming and requires collective cameras and markers that restrain natural body movements
PeaceHealth
Booth 416
careers.peacehealth.org
PeaceHealth, based in Vancouver, Washington, is a not-for-profit Catholic health system serving communities across Washington, Oregon, and Alaska . With approximately 17,000 caregivers, a medical group practice of more than 1,300 providers, and 9 medical centers, PeaceHealth delivers compassionate care to both urban and rural communities throughout the Pacific Northwest We’re proud to be nationally recognized for our commitment to caregiver health and wellness . Healthiest Employers named PeaceHealth one of the Healthiest 100 Workplaces in America, celebrating our dedication to fostering a culture of well-being . In addition, Springbuk ranked PeaceHealth as the No . 1 Healthiest Employer in Washington for the third consecutive year And in 2024, the Portland Business Journal honored PeaceHealth as Oregon’s No 1 Healthiest Employer Together, we continue to build a culture of care - where wellness, purpose, and connection thrive .
Pfizer Nurtec/Zavzpret
Booth 722
pfizer.com
About Pfizer: Breakthroughs That Change Patients’ Lives . At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines . Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time . Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world . For more than 170 years, we have worked to make a difference for all who rely on us . We routinely post information that may be important to investors on our website at www .Pfizer .com .In addition, to learn more, please visit us on www .Pfizer . com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook com/Pfizer
Piedmont Healthcare
Booth 610
piedmontcareers.org
Our Purpose is to make a positive difference in every life we touch, including yours . It governs every aspect of the holistic care we deliver and every interaction with our Piedmont family . From extraordinary wellness programs to professional growth opportunities, it’s the promise we keep every day — to our employees, volunteers, vendors, communities, and of course, our patients
PreventionGenetics LLC
Booth 721
preventiongenetics.com
At PreventionGenetics, we are passionate about human genetics and its power to improve lives Founded in 2004 and acquired in 2022 by global cancer diagnostics leader, Exact Sciences, PreventionGenetics is an accredited laboratory, delivering highquality genetic testing with exemplary service to patients, researchers and clinicians around the world . We provide tests for nearly all clinically relevant genes including our powerful and comprehensive whole-genome sequencing test, PGnome®, and wholeexome sequencing test, PGxome®
Revance Therapeutics
Booth 625
Revance.com
Revance Therapeutics brings innovation to the treatment of cervical dystonia with DAXXIFY®, the first and only FDA approved long-lasting botulinum toxin formulated with a novel custom engineered peptide . With a proven safety profile, Revance is advancing care and redefining possibilities for patients living with cervical dystonia .
RosmanSearch
Booth 508
rosmansearch.com/home/rosman.html
RosmanSearch is a specialized physician recruitment firm with an edge . Our unique approach blends data-driven insights with a highly focused team of recruiters, ensuring impactful placements . We don’t just fill positions; we leverage our expertise in neurosurgery, neurology, urology, gastroenterology, and hospitalist medicine to curate matches that elevate healthcare standards Whether permanent placement, executive search, or locum tenens, our experienced recruiters utilize robust data analytics and unparalleled expertise to deliver unmatched precision in every placement .
Sevaro
Booth 524
sevaro.com
Sevaro is a leading tele-neurology company committed to delivering cutting-edge neurological care through innovation, data, and compassion . We break down geographical barriers to healthcare by leveraging technology and top-tier clinical expertise, ensuring patients receive timely and effective care—wherever they are .
SK Life Science
Booth 323
SKLifeScienceInc.com
At SK Life Science we believe there is more to life when you connect health with happiness We are a pharmaceutical company dedicated to finding new treatments that will address the needs of those living with central nervous system disorders . Together with our parent company, SK Biopharmaceuticals, we have a pipeline of eight compounds in development in CNS and oncology . For more information, please visit us at www .SKLifeScienceInc .com . As long as there are unmet needs, we keep working
Sorridi Therapeutics
Booth 517
neurofiberhealth.com
Sorridi Therapeutics is pleased to introduce NeuroFiber at the 2025 AAN Fall Conference . Each NeuroFiber bar contains 11g of 14 prebiotic and whole food fibers . A clinical study in Parkinson’s Disease patients demonstrated constipation relief and a reduction in intestinal inflammation Please visit us at booth #517
Spartanburg Regional Healthcare System
Booth 410
spartanburgregional.com/careers/ physician-career-opportunties
Spartanburg Regional Healthcare System (SRHS) offers a full spectrum of services through six hospitals: Spartanburg Medical Center, Spartanburg Medical Center – Mary Black Campus, Pelham Medical Center, Spartanburg Hospital for Restorative Care, Cherokee Medical Center and Union Medical Center . SRHS also includes Ellen Sagar Nursing Center and Woodruff Manor, both skilled nursing and rehabilitation facilities SRHS provides unparalleled oncological care through the Gibbs Cancer Center & Research Institute The multidisciplinary Medical Group of the Carolinas has more than 600 physicians across the upstate of South Carolina and Western North Carolina .
SpringWorks Therapeutics
Booth 523
springworkstx.com
SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer
Supernus Pharmaceuticals, Inc.
Booth 611
supernus.com/commercial-products
At Supernus, we believe that our science has the potential to help people living with Parkinson’s disease (PD) . We’re committed to people with PD, their care partners, and the HCPs who help manage it Our currently available treatment options, and ongoing research, reflect our resolve to help the Parkinson’s community
Sutter Health
Booth 512
sutterhealth.org
Sutter Health is one of the nation’s leading community-based, not-forprofit health care networks which includes world-class hospitals, physician organizations, and a wide range of health care services With award-winning facilities across California, from the Pacific Coast to the Sierra Foothills – we proudly serve over 100 communities statewide . To view current opportunities check us out at: https://jobs .sutterhealthclinicians . org/
Takeda Booth 624
takeda.com
Takeda Neuroscience is driven by the unmet needs of patients with rare neurological diseases . Our mission is to bring innovative and potentially disease-modifying medicines to these patients To deliver on this mission, our approach leverages advances in molecularly and genetically defined targets, biomarkers, and targeted modalities . Our commitment to patients is focused on our goal of developing new treatments for those who need them most .
The Permanente Medical Group
Booth 408 northerncalifornia.permanente.org
The Permanente Medical Group’s 10,000 physicians and 40,000 nurses and staff lead the transformation of health care Through 80 years of tradition, nation-leading research, and superior technology systems, we deliver superior clinical outcomes with a positive and life-changing impact on the health of our Northern California patients . Take your career’s next step and join our team .
Tobii Dynavox
Booth 616
us.tobiidynavox.com
Tobii Dynavox is on a mission to provide touch and gaze-based speech generating devices, eye trackers, and communication apps along with funding support and training resources to empower people to do what they once did or never thought possible . Our team knows that success with AAC is a journey, and we’re here to guide you .
UCB, Inc.
Booth 424
UCB.com
UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system .
UCB, Inc.
Booth 309
ucb-usa.com
UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system
Universal Health Services (UHS)
Booth 415
Uhs.com
UHS currently operates, through its subsidiaries, more than 400 acute care hospitals, behavioral health facilities and ambulatory centers across the U .S . and U .K . As we continue to grow, we’re staying focused on making healthcare a more enriching, local experience .
Vivo Infusion
Booth 615
vivoinfusion.com
Vivo Infusion is a leading provider of accessible, affordable, communitybased infusion and injection care for patients suffering from compromised immune systems, cancer-related diagnoses, and other medical conditions . Vivo Infusion provides compassionate, expert care administered in safe, accessible facilities using efficient and cost-effective, patient-focused best practices Vivo currently serves communities in fifteen states, with plans to expand into additional markets For more information, visit: https:// vivoinfusion .com/.
Wellstar Health Systems
Booth 417
wellstar.org
Wellstar Health Systems is one of the largest and one of the more integrated healthcare systems in Georgia . Nationally ranked and locally recognized for our high-quality care inclusive culture and exceptional doctors As a not-for profit health system, our passion for people extends beyond our system and into the communities we serve . Across Wellstar Health System, our board-certified neurologists rely on world-class training and decades of combined experience to meet patients’ complete neurological needs . Come join our Team . Wellstar is currently seeking Neurologist, Out-Patient and some Tele-Medicine, and well as Advanced Practice Providers
AAN 2026 Annual Meeting
April 18-22, 2026
Chicago and Online Register now at AAN.com/AM
AAN Autoimmune Neurology Conference
August 7-8, 2026
Houston and Online
AAN APP Conference
October 8, 2026
Las Vegas and Online
AAN Fall Conference
October 9-11, 2026
Las Vegas and Online